Thursday, March 20, 2008

CHINA IS KILLING U.S. CITIZENS: THE DRUG HEPARIN IS CONTAMINATED, PATIENTS BEWARE!

Don't Say You Haven't Been Warned!

Christmas Toys, Hannah Montana accessories and now the very valuable and extremely necessary hospital drug HEPARIN have all been contaminated by China's manufactures. Americas has sold it's self to the Devil. When will we wake up. The US has spent years and years of testing perfecting and using the FDA to approve drugs. So where do we get off allowing China to supply so much of what is essential in our lives.

They don't have the same standards and dangerously the US Federal Government assumes they have the same standards! It is not going to happen and we have let too much in America get out-sourced to countries that are just one step above "developing nation" status. And I include China in that list, sorry. HEPARIN is a drug used to thin blood, clear veins and prevent bood clots, while administering other drugs. HEPARIN saves lives and our US supply is contaminated. America this is 'ROCKET SCIENCE' and we have let a country that doesn't have our standards, supply it to us.

Baxter International Inc.'s heparin was contaminated by a cheaper ingredient in China, that country said, confirming a finding from U.S. regulators probing deaths and allergic reactions linked to the blood-thinning medicine.

Tests showed traces of a substance known as over-sulfated chondroitin sulfate, the State Food and Drug Administration in Beijing said in a statement yesterday. The contaminant, a less expensive ingredient derived from animal cartilage, isn't approved in the U.S. for medical use, said Janet Woodcock, head of the U.S. Food and Drug Administration's drug division.

The finding gives investigators a new lead in their search for the cause of the dangerous side effects that prompted Baxter to withdraw the medicine, usually made from ingredients taken from pig intestines. Baxter, based in Deerfield, Illinois, supplied half the injectable heparin used in the U.S.
The Whole story is on BLOOMBERG.COM By Dune Lawrence and Justin Blum